Circassia Pharmaceuticals PLC (LSE:CIR) - Share price - Overview

Stock Report

Circassia Pharmaceuticals PLC CIR

Last Price
GBX86.50

Day Change
-3.25|-3.62%

As of 18/08/2017
16:35:13 BST | GBX
Minimum 15 Minutes Delay.

Last Close89.75p
Day Range86.50 - 90.25
Mkt Cap299.00Mil
52-Wk Range78.45 - 114.00
Yield %0.00
ISINGB00BJVD3B28
Volume20,766
P/E-4.17
P/S10.67
P/CF-4.40

Share Price

Total Returns 18/08/2017

 Chg (%)  
More ...
Circassia Pharmaceuticals PLC-3.62 
FTSE 100 TR GBP0.60
 
Financials
201420152016
More ...
Income Statement
Turnover0.0010.8023.10
Operating Profit-45.80-66.40-151.50
Net Profit-35.10-50.00-137.40
Reported EPS-21.00-20.00-48.00
Balance Sheet
Current Assets198.10223.70138.40
Non Current Assets2.40265.50195.70
Total Assets200.50489.20334.10
Current Liabilities9.7048.3021.50
Total Liabilities9.7079.5053.40
Total Equity190.80409.70280.70
Cash Flow
Operating Cash Flow-41.00-64.90-68.50
Net Change in Cash5.70135.70-72.70
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017-91.19-24.86--3.61---
2018-32.14-7.70--11.66---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
17/07/2017Exercise of OptionMr. Steven Harris0.08535,375428.00
02/06/2017Sale of Option SharesDr. Jean-Jacques Garaud89.1177,50069,060.00
02/06/2017Exercise of OptionDr. Jean-Jacques Garaud0.0877,50062.00

Company Profile

Circassia Pharmaceuticals PLC is a biotechnology company. It is engaged in the development and commercialization of range of therapies for asthma, chronic obstructive pulmonary disease, and allergy.

Sector

Biotechnology

Market Position

603 of 1846 Companies

Index

FTSE Small Cap ,FTSE All Share

Outlook

(28/04/2017) ceo - "...Circassia looks forward to further strengthening its business in 2017"

Next Event 27/09/2017

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)-6.3513.8016.61
Div Yld (E)0.004.014.19
PEG (E)0.000.631.11
ROCE-49.49183.00207.14
Op Mrgn-297.40-6.01-99.47
EPS Grwth0.0028.7723.71
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy1
Hold2
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanDr. Francesco Granata
Chief Executive OfficerMr. Steven Harris
Chief Financial Officer & Company SecretJulien Cotta
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.